CoChat

The impact of hepatitis C burden: an evidence‐based approach

Younossi, Z. M., Kanwal, F., Saab, S., Brown, K. A., El‐Serag, H. B., Kim, W. R., Ahmed, A., Kugelmas, M., Gordon, S. C. · 2014 · Alimentary Pharmacology & Therapeutics
Cited by 117

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Summary: Background: Infection with the hepatitis C virus (HCV) has been considered a major cause of mortality, morbidity and resource utilisation in the US. In addition, HCV is the main cause of hepatocellular cancer (HCC) in the US. Recent developments in the diagnosis and treatment of HCV, including new recommendations pertaining to screening for HCV by the Centers for Disease Control and Prevention and newer treatment regimens with high efficacy, short duration and the potential for interferon‐free therapies, have energised the health care practitioners regarding HCV management. Aim: To assess the full impact of HCV burden on clinical, economic and patient‐reported outcomes. Methods: An expert panel was convened to assess the full impact of HCV burden on a number of important outcomes using an evidence‐based approach predicated on Grading of Recommendations Assessment, Development and Evaluation methodology. The literature was summarised, graded using an evidence‐based approach and presented during the workshop. Workshop presentations were intended to review recent, relevant evidence‐based literature and provide graded summary statements pertaining to HCV burden on topics including the relationships between HCV and the development of important outcomes. Results: The associations of HCV with cirrhosis, HCC, liver‐related mortality, type 2 diabetes mellitus, rheumatological diseases and quality of life impairments are supported by strong evidence. Also, there is strong evidence that sustained viral eradication of HCV can improve important outcomes such as mortality and quality of life. Conclusions: The current evidence suggests that HCV has been associated with tremendous clinical, economic and quality of life burden.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/apt.12625

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 117

Metadata

Authors
Younossi, Z. M., Kanwal, F., Saab, S., Brown, K. A., El‐Serag, H. B., Kim, W. R., Ahmed, A., Kugelmas, M., & Gordon, S. C.
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2014-01-26
Volume
39
Issue
5
Pages
518-531
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W2032095674
Cited by
117
References
3
FWCI
12.31
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The impact of hepatitis C burden: an evidence‐based approach. https://app.cochat.ai/papers/10.1111/apt.12625
The paper
Younossi, Z. M., Kanwal, F., Saab, S., Brown, K. A., El‐Serag, H. B., Kim, W. R., Ahmed, A., Kugelmas, M., & Gordon, S. C. (2014). The impact of hepatitis C burden: an evidence‐based approach. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.12625

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.